Phase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients (PLEO-CMT)

Clinical trial NCT02579759 · COMPLETED

Trial details

NCT number: NCT02579759
Sponsor: Pharnext S.C.A.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Charcot-Marie-Tooth Disease Type 1A

Start date: 2015-12-01
Primary completion: 2018-03-01
Enrollment: 323

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.